Greater adoption of generics to drive the Mozambican pharma market, says Frost & Sullivan

Until recently, the pharmaceutical market in Mozambique had been inactive and largely donor-driven. However, in the last few years, it has experienced faster growth due to the large influx of affordable generic drugs, notes a new report from Frost & Sullivan.

For a country that had grappled with drug shortages for too long, the availability of low-cost generics has considerably improved access to medicines. Government health policy has been a key driver of this development. As part of wide-ranging reforms, the government instituted new drug registration measures aimed at curbing illegal imports, while at the same time promoting importation of legitimate generic products.

$110.5 million market by 2016